CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024

“Record-breaking revenue, new market entries, and transformative partnerships highlight our path to increasing shareholder value and long-term growth.”

SCOTTSDALE, AZ / ACCESSWIRE / October 8, 2024 / Dear Shareholders,

2024 has been a banner year for CBD Life Sciences, Inc. (CBDL), and we are thrilled to provide you with an exciting corporate update that underscores the massive growth and strategic advancements that are rapidly transforming our business. As of February 2024, we have achieved an extraordinary 1,405.46% increase in revenue, our highest to date, cementing CBDL as a dominant player in the booming CBD and wellness sectors.

This remarkable growth was driven by our aggressive expansion into new retail markets. By entering Amazon and Walmart Marketplace, two of the largest retail platforms globally, we have unlocked access to over $950 billion in combined annual consumer spending. This strategic move has resulted in a 300% growth in online sales since launch, and we’re just getting started.

Our product line continues to drive exceptional demand. The launch of our Mellow Mornings nano CBD coffee creamers, along with our fast-acting pain relief cream, has resonated deeply with consumers looking for innovative, effective solutions. In fact, early sales data shows a 500% increase in unit sales for our nano CBD products alone, and our partnerships with local coffee shops have expanded our reach exponentially, with CBD-infused beverages seeing an average 40% increase in customer orders.

Our entrance into the cannabis market, through partnerships with key dispensaries, is expected to fuel additional revenue growth in 2025, with the cannabis industry projected to reach $73.6 billion by 2027. Our pipeline is filled with potential, and we anticipate these moves will unlock multi-million-dollar opportunities for CBDL in the coming quarters.

We are not just scaling, but we are scaling smartly, with a 40% increase in gross margins year-over-year, thanks to our focus on high-margin products and streamlined operations. Furthermore, we are on track to deliver continued triple-digit growth, with projected revenues for 2024 set to surpass $10 million, driven by product innovation and continued retail expansion.

For shareholders, this means an extraordinary opportunity to capitalize on one of the fastest-growing companies in the CBD space. The company has no intentions of doing reverse split. Our relentless focus on innovation, strategic market entry, and partnerships with leading retailers positions us to not only meet but exceed your expectations in the near future.

Thank you for your continued confidence and trust as we chart a course to even greater heights.

Sincerely,
Lisa Nelson
President & CEO, CBD Life Sciences, Inc.

About CBD Life Sciences Inc.

CBD Life Sciences Inc. (OTC PINK:CBDL) is a forward-thinking, rapidly growing company specializing in the development of innovative, high-quality CBD products designed to enhance health and wellness. From pain relief to stress reduction, CBDL is at the forefront of the CBD revolution, consistently delivering premium products that meet the evolving needs of consumers. With a commitment to cutting-edge science and consumer satisfaction, CBDL is driving growth in the fast-expanding CBD market.

Follow our social media for the latest updates!

X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc’s, Inc.’s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information:

Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

SOURCE: CBD Life Sciences Inc.

View the original press release on accesswire.com